{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "original": "By THE ASSOCIATED PRESS", "person": [], "organization": "THE ASSOCIATED PRESS"}, "abstract": "Food and Drug Administration approves highly anticipated Pfizer drug Ibrance, used to treat postmenopausal women with specific type of advanced breast cancer.", "type_of_material": "Brief", "word_count": "120", "lead_paragraph": "The Food and Drug Administration approved Ibrance for women who have tumors that do not contain a protein known as HER-2.", "pub_date": "2015-02-04T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Pfizer Breast Cancer Drug Wins Federal Approval ", "content_kicker": "Business Briefing", "print_headline": "Pfizer Breast Cancer Drug Wins Federal Approval"}, "snippet": "The Food and Drug Administration approved Ibrance for women who have tumors that do not contain a protein known as HER-2.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/02/04/business/pfizer-breast-cancer-drug-wins-federal-approval.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Breast Cancer", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}], "blog": [], "_id": "54d1653538f0d86a52397ae3", "source": "The New York Times"}